Timothy B Doyle

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice

Yilmaz Emre Gençay, Camille Robert, Szabolcs Semsey et al. · Nature Biotechnology · 2023 · 238 citations · Full text

Life Sciences, Biotechnology, Microbiology +17

The Complex Flagellar Torque Generator of <i>Pseudomonas aeruginosa</i>

Timothy B Doyle, Andrew C. Hawkins, Linda L. McCarter · Journal of Bacteriology · 2004 · 143 citations

Life Sciences, Biology, Microbiology +15

Use of an Efflux-Deficient <i>Streptococcus pneumoniae</i> Strain Panel To Identify ABC-Class Multidrug Transporters Involved in Intrinsic Resistance to Antimicrobial Agents

Gregory T. Robertson, Timothy B Doyle, A. Simon Lynch · Antimicrobial Agents and Chemotherapy · 2005 · 70 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates

Mariana Castanheira, Timothy B Doyle, Timothy D. Collingsworth et al. · Journal of Antimicrobial Chemotherapy · 2021 · 70 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +15

In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in <i>Staphylococcus aureus</i>

Gregory T. Robertson, Eric J. Bonventre, Timothy B Doyle et al. · Antimicrobial Agents and Chemotherapy · 2008 · 68 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17